Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2012
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia
Hagop M Kantarjian, Xavier G Thomas, Anna Dmoszynska, et al.
Hematological Oncology
|
November 7, 2017
Role of BMI and age in predicting pathologic vertebral fractures in newly diagnosed multiple myeloma patients: A retrospective cohort study
Yi-Lun Chen, Yao-Chung Liu, Chia-Hung Wu, et al.
Medicine
|
March 18, 2016
Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients
Liang-Tsai Hsiao, Hao-Yuan Wang, Ching-Fen Yang, et al.
Annals of Hematology
|
July 2, 2020
Risk and impact of invasive fungal infections in patients with multiple myeloma
Chun-Kuang Tsai, Yao-Chung Liu, Ai Seon Kuan, et al.
Annals of Hematology
|
May 18, 2011
International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents
Sheng-Hsiang Yang, Hao-Wei Teng, Ying-Chung Hong, et al.
Annals of Hematology
|
May 29, 2013
Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era
Hsueh-Ju Lu, Yu-Chung Huang, Chun-Yu Liu, et al.
Annals of Hematology
|
June 19, 2013
Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
Yu-Chung Huang, Chun-Yu Liu, Hsueh-Ju Lu, et al.
Annals of Hematology
|
June 8, 2011
Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma
Yu-Chung Huang, Chia-Jen Liu, Chun-Yu Liu, et al.
Thrombosis and Haemostasis
|
April 27, 2012
A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system
Yuan-Bin Yu, Jyh-Pyng Gau, Chun-Yu Liu, et al.
Journal of Cancer
|
August 17, 2019
Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma
Chia-Hsin Lin, Ching-Fen Yang, Huai-Che Yang, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2012
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia
Hagop M Kantarjian, Xavier G Thomas, Anna Dmoszynska, et al.
Hematological Oncology
|
November 7, 2017
Role of BMI and age in predicting pathologic vertebral fractures in newly diagnosed multiple myeloma patients: A retrospective cohort study
Yi-Lun Chen, Yao-Chung Liu, Chia-Hung Wu, et al.
Medicine
|
March 18, 2016
Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients
Liang-Tsai Hsiao, Hao-Yuan Wang, Ching-Fen Yang, et al.
Annals of Hematology
|
July 2, 2020
Risk and impact of invasive fungal infections in patients with multiple myeloma
Chun-Kuang Tsai, Yao-Chung Liu, Ai Seon Kuan, et al.
Annals of Hematology
|
May 18, 2011
International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents
Sheng-Hsiang Yang, Hao-Wei Teng, Ying-Chung Hong, et al.
Annals of Hematology
|
May 29, 2013
Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era
Hsueh-Ju Lu, Yu-Chung Huang, Chun-Yu Liu, et al.
Annals of Hematology
|
June 19, 2013
Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
Yu-Chung Huang, Chun-Yu Liu, Hsueh-Ju Lu, et al.
Annals of Hematology
|
June 8, 2011
Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma
Yu-Chung Huang, Chia-Jen Liu, Chun-Yu Liu, et al.
Thrombosis and Haemostasis
|
April 27, 2012
A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system
Yuan-Bin Yu, Jyh-Pyng Gau, Chun-Yu Liu, et al.
Journal of Cancer
|
August 17, 2019
Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma
Chia-Hsin Lin, Ching-Fen Yang, Huai-Che Yang, et al.
Page
of 13